I
10.03
-0.03 (-0.30%)
| 前收盘价格 | 10.06 |
| 收盘价格 | 10.07 |
| 成交量 | 3,757,398 |
| 平均成交量 (3个月) | 1,144,520 |
| 市值 | 385,034,624 |
| 价格/销量 (P/S) | 8.63 |
| 股市价格/股市净资产 (P/B) | 0.480 |
| 52周波幅 | |
| 利润日期 | 6 Aug 2025 - 11 Aug 2025 |
| 营业利益率 (TTM) | -448.03% |
| 稀释每股收益 (EPS TTM) | -3.32 |
| 总债务/股东权益 (D/E MRQ) | 0.86% |
| 流动比率 (MRQ) | 12.62 |
| 营业现金流 (OCF TTM) | -98.18 M |
| 杠杆自由现金流 (LFCF TTM) | -64.35 M |
| 资产报酬率 (ROA TTM) | -14.47% |
| 股东权益报酬率 (ROE TTM) | -23.07% |
市场趋势
| 短期 | 中期 | ||
| 行业 | Biotechnology (US) | 看跌 | 看跌 |
| Biotechnology (全球的) | 看跌 | 看跌 | |
| 股票 | iTeos Therapeutics, Inc. | 看跌 | 看跌 |
AIStockmoo 评分
0.5
| 分析师共识 | -0.5 |
| 内部交易活动 | NA |
| 价格波动 | -2.0 |
| 技术平均移动指标 | 2.5 |
| 技术振荡指标 | 2.0 |
| 平均 | 0.50 |
|
ITeos Therapeutics Inc is a biopharmaceutical company. It designs novel product candidates with optimized pharmacologic properties to improve clinical outcomes by restoring the immune response against cancer. The company's product candidates include EOS-850 which is an Adenosine A2A receptor-specific antagonist, EOS-448 which is an ADCC-enabled, anti-TIGIT immune checkpoint blocking antibody among other drug candidates. |
|
| 部门 | Healthcare |
| 行业 | Biotechnology |
| 投资方式 | Small Value |
| 内部持股比例 | 1.13% |
| 机构持股比例 | 90.87% |
所有权
| 姓名 | 日期 | 持有股份 |
|---|---|---|
| Mpm Asset Management Llc | 31 Mar 2025 | 2,738,785 |
| Mpm Bioimpact Llc | 31 Mar 2025 | 1,745,943 |
| 52周波幅 | ||
| 目标价格波幅 | ||
| 高 | 46.00 (HC Wainwright & Co., 358.62%) | 购买 |
| 中 | 12.00 (19.64%) | |
| 低 | 8.00 (JP Morgan, -20.24%) | 保留 |
| 平均值 | 16.50 (64.51%) | |
| 总计 | 2 购买, 4 保留 | |
| 平均价格@调整类型 | 8.38 | |
| 公司 | 日期 | 目标价格 | 调整类型 | 价格@调整类型 |
|---|---|---|---|---|
| Wedbush | 28 May 2025 | 12.00 (19.64%) | 保留 | 10.06 |
| Wells Fargo | 28 May 2025 | 12.00 (19.64%) | 保留 | 10.06 |
| 14 May 2025 | 13.00 (29.61%) | 购买 | 7.60 | |
| Leerink Partners | 14 May 2025 | 9.00 (-10.27%) | 保留 | 7.60 |
| Piper Sandler | 14 May 2025 | 12.00 (19.64%) | 购买 | 7.60 |
| JP Morgan | 13 May 2025 | 8.00 (-20.24%) | 保留 | 7.85 |
| 06 Mar 2025 | 15.00 (49.55%) | 购买 | 7.10 | |
| HC Wainwright & Co. | 06 Mar 2025 | 46.00 (358.62%) | 购买 | 7.10 |
该时间范围内无数据。
支撑、阻力和趋势线水平是由人工智能（AI）模型生成的，请谨慎解读。
投资组合